Swiss-based Lonza has just opened the world’s largest dedicated cell-and-gene-therapy manufacturing facility in Pearland, Texas, with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases. The 300,000 square foot state-of-the art facility is the first-of-its-kind and will deploy some of the world’s most innovative cell-and-gene-therapy manufacturing technologies. The Lonza Houston Center of Excellence will house more than 200 full-time employees including scientists, engineers, MBA graduates and biotechnology professionals by the end of 2018, and continue to recruit high-value positions as market demand increases.